Parkinson Disease/ Parkinsonian Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 191-200 of 407 total displayed.

Past content

Correspondence
Fluorodopa F 18 Positron Emission Tomography and the Progression of Parkinson Disease—Reply

Ruediger Hilker; Karl Herholz; Wolf-Dieter Heiss
Arch Neurol 2005; 62: 1480-a-1481-a. [Extract] [Full text] [PDF]  

Correspondence
Fluorodopa F 18 Positron Emission Tomography and the Progression of Parkinson Disease

Per Borghammer; Yoshitaka Kumakura; Paul Cumming
Arch Neurol 2005; 62: 1480. [Extract] [Full text] [PDF]  

Original Contributions
Sudden Uncontrollable Somnolence and Medication Use in Parkinson Disease

Jerry Avorn; Sebastian Schneeweiss; Lewis R. Sudarsky; Joshua Benner; Yuka Kiyota; Raisa Levin; Robert J. Glynn
Arch Neurol 2005; 62: 1242-1248. [Abstract] [Full text] [PDF]  

Original Contributions
Management of Referred Deep Brain Stimulation Failures: A Retrospective Analysis From 2 Movement Disorders Centers

Michael S. Okun; Michele Tagliati; Michael Pourfar; Hubert H. Fernandez; Ramon L. Rodriguez; Ron L. Alterman; Kelly D. Foote
Arch Neurol 2005; 62: 1250-1255. [Abstract] [Full text] [PDF]  

Original Contributions
Prognosis of Parkinson Disease: Risk of Dementia and Mortality: The Rotterdam Study

Lonneke M. L. de Lau; C. Maarten A. Schipper; Albert Hofman; Peter J. Koudstaal; Monique M. B. Breteler
Arch Neurol 2005; 62: 1265-1269. [Abstract] [Full text] [PDF]  

Observations
Pleuropulmonary Fibrosis After Long-term Treatment With the Dopamine Agonist Pergolide for Parkinson Disease

Ron Tintner; Prasad Manian; Polly Gauthier; Joseph Jankovic
Arch Neurol 2005; 62: 1290-1295. [Abstract] [Full text] [PDF]  

Correspondence
Reexamination of the TEMPO Study

Clifford W. Shults
Arch Neurol 2005; 62: 1320. [Extract] [Full text] [PDF]  

Correspondence
Reexamination of the TEMPO Study—Reply

Andrew Siderowf; Shirley Eberly; David Oakes; Ira Shoulson; for the Parkinson Study Group TEMPO Steering Committee
Arch Neurol 2005; 62: 1321-a. [Extract] [Full text] [PDF]  

Original Contributions
Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease

M. Leann Dodd; Kevin J. Klos; James H. Bower; Yonas E. Geda; Keith A. Josephs; J. Eric Ahlskog
Arch Neurol 62.9.noc50009. [Abstract] [Full text] [PDF]  

Original Contributions
Intermittent vs Continuous Levodopa Administration in Patients With Advanced Parkinson Disease: A Clinical and Pharmacokinetic Study

Fabrizio Stocchi; Laura Vacca; Stefano Ruggieri; C. Warren Olanow
Arch Neurol 2005; 62: 905-910. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41